Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy



Status:Recruiting
Conditions:Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:2 - 99
Updated:4/21/2016
Start Date:August 2013
End Date:August 2016
Contact:Ashlee Forti
Email:vtpp@registratmapi.com
Phone:877-776-0999

Use our guide to learn which trials are right for you!

A Point Prevalence Study to Evaluate the Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Who Are Receiving Porcine-Derived Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors

This is a point prevalence study conducted entirely in the United States (US) to establish
the prevalence of antibodies to hepatitis E virus (HEV) and other selected porcine viruses
in cystic fibrosis (CF) patients receiving pancreatic enzyme replacement therapy (PERT) for
pancreatic insufficiency compared with matched (age and region of residence) control
patients unexposed to PERT.

This is a multicenter, non-interventional point-prevalence study conducted in the US to
determine the seroprevalence of antibodies to selected porcine viruses in pancreatic enzyme
replacement therapy-exposed CF patients and in an unexposed control group matched for age
and geographic region of residence. Data collection includes demographic and medical
history, pancreatic enzyme replacement therapy, transfusion history, and history of
potential exposure to pig viruses. If a patient meets all the requirements of the study and
provides a study specific informed consent/assent, a single blood sample is obtained as part
of a planned standard-of-care blood collection.

This harmonized protocol reflects equal sponsorship not only by the registering Sponsor,
AbbVie, but also the Collaborators, Aptalis Pharma and Janssen Research & Development, LLC.

Inclusion Criteria:

All Patients (PERT-exposed and unexposed controls) must meet the following criteria:

- Have a blood draw planned as part of their standard of care following enrollment into
the study; and

- Provide informed consent/assent.

Patients in the PERT-Exposed Group must meet the following criteria:

- Have been diagnosed with CF; and

- Have received PERT for a minimum of 6 months.

Patients in the Unexposed Control Group must meet the following criteria:

- Be under medical management for chronic disease;

- Never received any PERT product; and

- Match an enrolled PERT-exposed patient based on age and region-of-residence.

Exclusion Criteria:

- Has a porcine heart valve, a porcine-derived graft, or has had exposure to porcine
derived insulin. This exclusion does not apply to previous porcine-derived heparin
exposure. ;

- Refuses blood collection; or

- Has any condition that, in the opinion of the investigator, would make participation
not be in the best interest (e.g., compromise the well-being) of the patient or that
could prevent, limit, or confound the protocol-specified assessments.
We found this trial at
55
sites
Maywood, Illinois 60153
Principal Investigator: Site Reference ID/Investigator# 116465, MD
?
mi
from
Maywood, IL
Click here to add this to my saved trials
Anchorage, Alaska
Principal Investigator: Site Reference ID/Investigator# 116382, MD
?
mi
from
Anchorage, AK
Click here to add this to my saved trials
Atlanta, Georgia
Principal Investigator: Site Reference ID/Investigator# 131935, MD
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Boise, Idaho 83712
Principal Investigator: Site Reference ID/Investigator# 116452, MD
?
mi
from
Boise, ID
Click here to add this to my saved trials
Boston, Massachusetts
Principal Investigator: Site Reference ID/Investigator# 116461, MD
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Buffalo, NY
Click here to add this to my saved trials
Charleston, South Carolina 29412
Principal Investigator: Site Reference ID/Investigator# 116462, MD
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Chicago, Illinois
Principal Investigator: Site Reference ID/Investigator# 116442, MD
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Cincinnati, Ohio
Principal Investigator: Site Reference ID/Investigator# 116458, MD
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cleveland, Ohio
Principal Investigator: Site Reference ID/Investigator# 116881, MD
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
Detroit, MI
Click here to add this to my saved trials
?
mi
from
Durham, NC
Click here to add this to my saved trials
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
?
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Hatford, Connecticut 06106
Principal Investigator: Site Reference ID/Investigator# 116441, MD
?
mi
from
Hatford, CT
Click here to add this to my saved trials
Hershey, Pennsylvania 17033
Principal Investigator: Site Reference ID/Investigator# 116457, MD
?
mi
from
Hershey, PA
Click here to add this to my saved trials
Houston, Texas
Principal Investigator: Site Reference ID/Investigator# 116856, MD
?
mi
from
Houston, TX
Click here to add this to my saved trials
Indianapolis, Indiana 46202
Principal Investigator: Site Reference ID/Investigator# 116877, MD
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Jackson, Mississippi 39216
Principal Investigator: Site Reference ID/Investigator# 116445, MD
?
mi
from
Jackson, MS
Click here to add this to my saved trials
?
mi
from
Knoxville, TN
Click here to add this to my saved trials
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
Little Rock, Arkansas
Principal Investigator: Site Reference ID/Investigator# 116444, MD
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
Long Beach, California 90806
Principal Investigator: Site Reference ID/Investigator# 116595, MD
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
Los Angeles, California
Principal Investigator: Site Reference ID/Investigator# 116448, MD
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Louisville, Kentucky 40202
Principal Investigator: Site Reference ID/Investigator# 136816, MD
?
mi
from
Louisville, KY
Click here to add this to my saved trials
?
mi
from
Madison, WI
Click here to add this to my saved trials
Miami, Florida 33136
Principal Investigator: Site Reference ID/Investigator# 116882, MD
?
mi
from
Miami, FL
Click here to add this to my saved trials
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Morgantown, West Virginia
Principal Investigator: Site Reference ID/Investigator# 116438, MD
?
mi
from
Morgantown, WV
Click here to add this to my saved trials
New Haven, Connecticut
Principal Investigator: Site Reference ID/Investigator# 127584, MD
?
mi
from
New Haven, CT
Click here to add this to my saved trials
New Hyde Park, New York 11040
Principal Investigator: Site Reference ID/Investigator# 130461, MD
?
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
New Orleans, Louisiana
Principal Investigator: Site Reference ID/Investigator# 116450, MD
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
Niles, Illinois 60714
Principal Investigator: Site Reference ID/Investigator# 141881, MD
?
mi
from
Niles, IL
Click here to add this to my saved trials
Norfolk, Virginia 23507
Principal Investigator: Site Reference ID/Investigator# 116278, MD
?
mi
from
Norfolk, VA
Click here to add this to my saved trials
Oklahoma City, Oklahoma
Principal Investigator: Site Reference ID/Investigator# 116464, MD
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Omaha, Nebraska
Principal Investigator: Site Reference ID/Investigator# 116883, MD
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Orlando, Florida 32804
Principal Investigator: Site Reference ID/Investigator# 116277, MD
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Peoria, Illinois 61603
Principal Investigator: Site Reference ID/Investigator# 127295, MD
?
mi
from
Peoria, IL
Click here to add this to my saved trials
Philadelphia, Pennsylvania
Principal Investigator: Site Reference ID/Investigator# 116467, MD
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pittsburgh, Pennsylvania
Principal Investigator: Site Reference ID/Investigator# 116466, MD
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Richmond, Virginia 23227
Principal Investigator: Site Reference ID/Investigator# 116460, MD
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Shreveport, Louisiana 71103
Principal Investigator: Site Reference ID/Investigator# 116455, MD
?
mi
from
Shreveport, LA
Click here to add this to my saved trials
Sioux Falls, South Dakota
Principal Investigator: Site Reference ID/Investigator# 116453, MD
?
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Syracuse, New York 13202
Principal Investigator: Site Reference ID/Investigator# 116449, MD
?
mi
from
Syracuse, NY
Click here to add this to my saved trials
Tampa, Florida
Principal Investigator: Site Reference ID/Investigator# 116435, MD
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Toledo, Ohio 43608
Principal Investigator: Site Reference ID/Investigator# 116276, MD
?
mi
from
Toledo, OH
Click here to add this to my saved trials
Tyler, Texas 75702
Principal Investigator: Site Reference ID/Investigator# 116459, MD
?
mi
from
Tyler, TX
Click here to add this to my saved trials
Wichita, Kansas 67214
Principal Investigator: Site Reference ID/Investigator# 116436, MD
?
mi
from
Wichita, KS
Click here to add this to my saved trials